Termination of pregnancy
Overview
•Two registered medical practitioners must certify in good faith that a ground applies (one suffices in a genuine emergency)
•Must be performed in a licensed NHS hospital or independent sector clinic
Ground | Indication | Gestational limit |
A (social) | Continuing pregnancy poses greater risk to physical/mental health of woman or existing children than termination | Up to 24 weeks |
B (grave injury) | Necessary to prevent grave permanent injury to physical/mental health of woman | No limit |
C (risk to life) | Continuing pregnancy poses greater risk to life of woman than termination | No limit |
D (fetal abnormality) | Substantial risk child would be seriously handicapped | No limit |
•Conscientious objection is permitted (Section 4) but the practitioner must refer the woman to a willing colleague and must provide emergency care if her life is at risk
Management
•Confirm gestation by ultrasound before proceeding; offer impartial counselling on all options (continuation, adoption, termination) and discuss contraception
•Medical TOP - sequential regimen (simultaneous administration not recommended):
•Step 1 - mifepristone 200 mg orally (progesterone receptor antagonist - decidual breakdown, cervical priming, myometrial sensitisation)
•Step 2 - misoprostol 24-48 hours later (prostaglandin E1 analogue - uterine contractions, expulsion)
•≤10 weeks: misoprostol can be taken at home after in-clinic mifepristone
•10-24 weeks: managed in clinic/day-case unit
•From ~22 weeks: feticide (intracardiac potassium chloride) required before induction to prevent live birth
•Surgical TOP:
•Vacuum aspiration - up to ~14 weeks, outpatient under local anaesthetic
•D&E - 14-24 weeks, theatre under GA; cervical priming with misoprostol or osmotic dilators beforehand
Prophylaxis
•Anti-D: offer anti-D immunoglobulin to all rhesus-D negative women from 10 weeks gestation onwards (both MTOP and STOP); also consider for surgical abortion before 10 weeks
•Antibiotic prophylaxis: all women - doxycycline or metronidazole per local protocol (reduces post-abortion infection/PID risk)
•VTE prophylaxis: enoxaparin (LMWH) for at least 7 days post-procedure in high-risk women
Follow-up
•Urine pregnancy test at 3 weeks post-procedure - if positive, review to exclude RPOC or ongoing pregnancy
•Contraception can be commenced immediately after TOP
Complications
•Incomplete termination - RPOC after MTOP; more common with medical than surgical method; requires surgical evacuation
•Haemorrhage - both methods; uterine atony/vessel injury with surgical TOP
•Infection - PID/endometritis, especially with RPOC; reduced by antibiotic prophylaxis
•Uterine perforation - rare; surgical TOP (D&E), higher risk with advancing gestation
•Failed termination - ongoing pregnancy; repeat procedure required
Medical vs Surgical Termination
Medical vs surgical termination of pregnancy
| Feature | Medical (MTOP) | Surgical (STOP) |
|---|---|---|
| Method | Mifepristone then misoprostol | Vacuum aspiration (≤14 wks) or D&E (14-24 wks) |
| Gestational range | Up to 24 weeks | Up to 24 weeks |
| Setting | Home (≤10 wks); clinic/day-case (10-24 wks) | Outpatient LA (vacuum) or theatre GA (D&E) |
| Key complication | Incomplete expulsion - RPOC requiring surgical evacuation | Uterine perforation, cervical injury |